Venous News

Several late-breaking data presentations have been shared at #VIVA24 over the last few days, including on Penumbra, Inc.'s computer-assisted vacuum thrombectomy (CAVT) technology for #PulmonaryEmbolism Read more: https://lnkd.in/ddU3n-xz

Inquis Medical, Inc. has announced the successful closure of its US$40 million series B financing round. This round was led by Marshall Wace, a globally recognised investment firm, with participation from existing investors. Vahid Saadat Mojgan Saadat Andrew D. Goldberg, MD https://lnkd.in/eU27WkJq

INTERVIEW: “One of the great and simultaneously worrisome things about venous disease is that we’re still in the first generation of our understanding of pathophysiology and therapies. It’s really exciting in the sense that there’s so much more to go in our lifetimes, and we can’t get complacent,” Kush Desai, professor of radiology, surgery, and medicine at Northwestern University - The Feinberg School of Medicine, tells Venous News while detailing his career and what’s next in venous care. Read more: https://lnkd.in/gv79qtTC

Cook Medical’s Zilver Vena venous self-expanding stent has shown high rates of patency sustained for three years, according to recently published data in the JOURNAL OF VASCULAR & INTERVENTIONAL RADIOLOGY (JVIR Media). The patency results extended across all patient subgroups, and patients experienced improvements in clinical scoring as compared to baseline. Alec Cerchiari Anthony Comerota MD FACS FACC https://lnkd.in/eRZkHcZE

ABRE subanalysis highlights obesity ‘paradox’ in post-venous stenting outcomes https://lnkd.in/eHwHeTUr

Sonablate Corp. has announced the first patient enrolled in the HIFIVE clinical trial in the USA under the guidance of principal investigator, Naiem Nassiri, M.D., F.S.V.S., R.P.V.I. (The Vascular Care Group, Massachusetts, USA). Naren Sanghvi Richard Yang https://lnkd.in/emicc3fG

Published in the Journal of Thrombosis and Thrombolysis, new research with a follow-up of 27 years has found an association between high levels of physical activity and an elevated risk of venous thromboembolism (#VTE). Per Wändell Karolinska Institutet

InterVene, Inc. recently announced the closing of its US$13 million Series A financing round. The financing was co-led by new investor Treo Ventures and existing investor RiverVest Venture Partners. Read more: https://lnkd.in/ezyB2FCh Jeff Elkins Jay Schmelter Stephen Black

A new deep vein thrombosis (#DVT) diagnostic pathway incorporating non-expert artificial intelligence (#AI)-guided compression ultrasound could reduce workload and costs for #healthcare systems while providing a quicker diagnosis and improving patient care. Efthymios (Makis) Avgerinos (Athens, Greece) shared this key conclusion from a pilot study of the ThinkSono guidance system (ThinkSono) at the 2024 European Society for Vascular Surgery (ESVS) annual meeting (24–27 September, Kraków, Poland). Read more: https://lnkd.in/eCK5Gixd

B. Braun Medical Inc. (US) has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Introcan Safety 2 deep access intravenous (IV) catheter, the newest addition to the Introcan Safety 2 IV catheter portfolio. Chad Laity https://lnkd.in/eNrhbKVt